Pharmaceutical Business review

Acacia Research signs licensing agreement with Infinitt North America

This agreement resolves the parties’ dispute that was pending in the District Court of Texas.

Acacia Research’s subsidiaries develop, acquire, and license patented technologies. They control over 100 patent portfolios, which include US patents and certain foreign counterparts, covering technologies used in a wide variety of industries.